These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1963587)

  • 1. Effect of TGF-beta on the proliferation of B cell lines and on the immortalisation of B cells by EBV.
    Altiok A; Bejarano MT; Klein E
    Curr Top Microbiol Immunol; 1990; 166():375-80. PubMed ID: 1963587
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr virus gene expression during primary B-lymphocyte infection, in transformed and Burkitt lymphoma-derived cell lines.
    Ernberg I; Kallin B; Dillner J
    Curr Top Microbiol Immunol; 1986; 132():251-6. PubMed ID: 3024918
    [No Abstract]   [Full Text] [Related]  

  • 3. Epstein-Barr virus antagonizes the antiproliferative activity of transforming growth factor-beta but does not abolish its signaling.
    Horndasch M; Raschke EE; Bommer G; Schuhmacher M; Dumont E; Kuklik-Roos C; Eick D; Kempkes B
    Int J Cancer; 2002 Oct; 101(5):442-7. PubMed ID: 12216072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells.
    Arvanitakis L; Yaseen N; Sharma S
    J Immunol; 1995 Aug; 155(3):1047-56. PubMed ID: 7636179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of transforming growth factor-beta 1 and -beta 2 on the proliferation of Burkitt lymphoma and lymphoblastoid cell lines.
    Altiok A; Bejarano MT; Ruscetti F; Altiok E; Klein G; Klein E
    Growth Factors; 1991; 4(2):117-28. PubMed ID: 1646619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV-activation of human B-lymphocytes.
    Aman P; Lewin N; Nordström M; Klein G
    Curr Top Microbiol Immunol; 1986; 132():266-71. PubMed ID: 3024919
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of TGF-beta 1 on the EBV-induced transformation of human lymphocyte cultures.
    Altiok A; Bejarano MT; Klein G; Klein E
    Int J Cancer; 1992 Mar; 50(5):772-6. PubMed ID: 1312065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.
    Cuomo L; Trivedi P; de Campos-Lima PO; Zhang QJ; Ragnar E; Klein G; Masucci MG
    Mol Immunol; 1993 Apr; 30(5):441-50. PubMed ID: 7681932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
    Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the Epstein-Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability and tumorigenicity of an EBV-negative Burkitt lymphoma line.
    Cuomo L; Ramquist T; Trivedi P; Wang F; Klein G; Masucci MG
    Int J Cancer; 1992 Jul; 51(6):949-55. PubMed ID: 1322379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus terminal protein gene transcription is dependent on EBNA2 expression and provides evidence for viral integration into the host genome.
    Zimber-Strobl U; Suentzenich K; Falk M; Laux G; Cordier M; Calender A; Billaud M; Lenoir GM; Bornkamm GW
    Curr Top Microbiol Immunol; 1990; 166():359-66. PubMed ID: 1963585
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis.
    Gregory CD; Dive C; Henderson S; Smith CA; Williams GT; Gordon J; Rickinson AB
    Nature; 1991 Feb; 349(6310):612-4. PubMed ID: 1705663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the growth-inhibitory effect of TGF-beta 1 and phenotypic characteristics in a panel of B-cell lines.
    Altiok A; Ehlin-Henriksson B; Klein E
    Int J Cancer; 1993 Aug; 55(1):137-40. PubMed ID: 8393838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
    Aguirre AJ; Robertson ES
    J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines.
    Inman GJ; Allday MJ
    J Gen Virol; 2000 Jun; 81(Pt 6):1567-78. PubMed ID: 10811940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines.
    Kempkes B; Zimber-Strobl U; Eissner G; Pawlita M; Falk M; Hammerschmidt W; Bornkamm GW
    J Gen Virol; 1996 Feb; 77 ( Pt 2 )():227-37. PubMed ID: 8627226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
    Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
    Doyle MG; Crawford DH
    Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid and steroids inhibit Epstein-Barr virus-induced nuclear antigen, DNA synthesis and lymphocyte transformation.
    Sundar SK; Levine PH; Ablashi DV; Menezes J
    Anticancer Res; 1984; 4(6):415-8. PubMed ID: 6097161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.